Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review

Area of Science:

• Cardiology
• Public Health

Background:

• Coronary heart disease (CHD) is a chronic, systemic condition with significant health care costs.
• Adverse events in CHD can be managed through lifestyle modifications, risk factor control, and medical therapy.
• Prevention and medical treatments are increasingly effective in managing atherosclerotic disease and thrombosis.

Purpose of the Study:

• To review scientific evidence for medical therapy and revascularization in stable coronary heart disease.
• To discuss implications for patient evaluation and public policy regarding stable angina management.

Main Methods:

• Review of scientific evidence.
• Analysis of current treatment paradigms for stable coronary heart disease.

Main Results:

• Medical therapy and lifestyle changes effectively slow CHD progression and reduce thrombotic risks.
• The necessity of coronary artery revascularization is diminishing, now primarily for specific patient subgroups.
• There is a critical need for optimized resource allocation towards prevention strategies.

Conclusions:

• Medical management and prevention are paramount in treating stable coronary heart disease.
• Revascularization is reserved for select patients with severe symptoms or high-risk anatomy.
• Public policy and clinical evaluation should prioritize enhanced prevention efforts for CHD.